Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Shinn

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Science Translational Medicine|April 29, 2011
The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomicsRuili Huang, Noel Southall, Yuhong Wang, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Retro Drug Design: From Target Properties to Molecular StructuresYuhong Wang, Sam Michael, Ruili Huang, et al.
Journal of Biomolecular Screening|June 2, 2009
Monitoring compound integrity with cytochrome P450 assays and qHTSRyan MacArthur, William Leister, Henrike Veith, et al.
ACS Pharmacology & Translational Science|December 17, 2020
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity AssayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
JALA (Charlottesville, Va.)|May 23, 2008
Compound Management for Quantitative High-Throughput ScreeningAdam Yasgar, Paul Shinn, Ajit Jadhav, et al.
ACS Pharmacology & Translational Science|August 15, 2024
A Comprehensive Collection of Pain and Opioid Use Disorder Compounds for High-Throughput Screening and Artificial Intelligence-Driven Drug DiscoveryXin Hu, Paul Shinn, Zina Itkin, et al.
Assay and Drug Development Technologies|March 17, 2010
A multiplex calcium assay for identification of GPCR agonists and antagonistsKe Liu, Noel Southall, Steve A Titus, et al.
Current Protocols in Chemical Biology|January 7, 2014
Multiplexing high-content flow (HCF) and quantitative high-throughput screening (qHTS) to identify compounds capable of decreasing cell viability, activating caspase 3/7, expressing annexin V, and changing mitochondrial membrane integrityLesley A Mathews, Jonathan M Keller, Crystal McKnight, et al.
Malaria Journal|April 15, 2017
Novel lead structures with both Plasmodium falciparum gametocytocidal and asexual blood stage activity identified from high throughput compound screeningWei Sun, Xiuli Huang, Hao Li, et al.
Disease Models & Mechanisms|March 27, 2015
Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasionViviana E Gallardo, Gaurav K Varshney, Minnkyong Lee, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Science Translational Medicine|April 29, 2011
The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomicsRuili Huang, Noel Southall, Yuhong Wang, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Retro Drug Design: From Target Properties to Molecular StructuresYuhong Wang, Sam Michael, Ruili Huang, et al.
Journal of Biomolecular Screening|June 2, 2009
Monitoring compound integrity with cytochrome P450 assays and qHTSRyan MacArthur, William Leister, Henrike Veith, et al.
ACS Pharmacology & Translational Science|December 17, 2020
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity AssayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
JALA (Charlottesville, Va.)|May 23, 2008
Compound Management for Quantitative High-Throughput ScreeningAdam Yasgar, Paul Shinn, Ajit Jadhav, et al.
ACS Pharmacology & Translational Science|August 15, 2024
A Comprehensive Collection of Pain and Opioid Use Disorder Compounds for High-Throughput Screening and Artificial Intelligence-Driven Drug DiscoveryXin Hu, Paul Shinn, Zina Itkin, et al.
Assay and Drug Development Technologies|March 17, 2010
A multiplex calcium assay for identification of GPCR agonists and antagonistsKe Liu, Noel Southall, Steve A Titus, et al.
Current Protocols in Chemical Biology|January 7, 2014
Multiplexing high-content flow (HCF) and quantitative high-throughput screening (qHTS) to identify compounds capable of decreasing cell viability, activating caspase 3/7, expressing annexin V, and changing mitochondrial membrane integrityLesley A Mathews, Jonathan M Keller, Crystal McKnight, et al.
Malaria Journal|April 15, 2017
Novel lead structures with both Plasmodium falciparum gametocytocidal and asexual blood stage activity identified from high throughput compound screeningWei Sun, Xiuli Huang, Hao Li, et al.
Disease Models & Mechanisms|March 27, 2015
Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasionViviana E Gallardo, Gaurav K Varshney, Minnkyong Lee, et al.
Pageof 10